Thursday, November 3, 2016

Indices down .01% to .64%.....

Indices are following a familiar pattern of a very weak TAPE, start green and lose it all, then go towards low of the day. Oil is down again and election playing a decisive role in market direction.

S&P 500 @ 2092.05, low 2091.01, high 2102.56

Internals are negative 

Oil Down 90 cents

Gold Down $6.00

Canadian $ UP 3 tick @ .6615

VIX UP 8.95% @ 21.05

Portfolio AMD AAPL BIDU CNQ CMG TWLO VRX

Most stocks are down

@ 2.31 following are green :

BIDU CMG TCK AKS NTES QRVO CTRP ABX KGC
OLED EXPE FFIV FNSR CHK RIG LNG WB FCX
ZG GS TRIP ORCL SLW AEM CRUS X M.....

After close TWLO reports, here are the expectations :

Sales $66.77 million, EPS loss of 8 cents

Guidance next Q Sales $69.69 million, EPS loss of 6 cents

This is a new IPO, it has crashed from high of $70.96, last trade $32.87

Hard to tell, what is going on in this stock......AH should reveal....

BLOG does NOT give buy or sell.

Saleem

7 comments:

Stocks100 said...


Hi Stocktrader,

Sold 40% CNQ @ $3.50.

Saleem

stocktrader_1996 said...

Hi Saleem,

Good luck with CNQ proceeds.

Quick look at QRVO says they are still having major margin problems. The hits keep coming for me today...

Stocktrader

Stocks100 said...


Hi Stocktrader,

There was a typo...i sold 40% CNQ @ $30.50......

YES... some days are very tough, mine has been drip drip in TWLO & VRX...

Saleem

joseph said...


Hi Saleem and stocktrader,

These days the market has been tough for all of us. I wanted to add more TRIL today, but I decided not to add more. I dont want to have too much exposure in bio tech since the election is just around the corner.

Let us hope things will turn around after the election.

Joseph

stocktrader_1996 said...

Hi Joseph,

TRIL really is heartbreaking. I am very surprised at the price action today, but there is not much confidence anywhere in the market, and definitely not in biotech. There is so much to like about TRIL, and frankly, these dose-escalating results really didn't change that outlook in my opinion, hence the confusion. I'm looking forward to early efficacy results next month--if it kills platelets that well, it should kill the tumor with great effect also.

Stocktrader

stocktrader_1996 said...

Hi Saleem,

QRVO is guiding through the next 1.5 years as far as revenue growth (double digits guided vs 7% expected), gross margin above 50% (vs 42.8% this quarter), and operating margin above 30% (due to OpEx% trending lower in conjunction with the higher gross margin). I'm doubt the market completely trusts them given they've messed up this yield issue so badly, but if they are anywhere close to their guided numbers, the stock could easily be $75+.

Stocktrader

Stocks100 said...


Hi Stocktrader & Joseph,

Thanks for your take on QRVO, TRIL and market in general.

It is really tough for every participant.

Good luck!

Saleem